WHO halts hydroxychloroquine, lopinavir/ritonavir trials for COVID-19 treatment
Published
WHO says interim trial results show hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients
The post WHO halts hydroxychloroquine, lopinavir/ritonavir trials for COVID-19 treatment appeared first on Premium Times Nigeria.